Linustedastat
3-[(8R,9S,13S,14S,15R,17E)-4-fluoro-17-hydroxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-fluoro-2-pyridinyl)propanamide
Molecular Identity
Linustedastat
3-[(8R,9S,13S,14S,15R,17E)-4-fluoro-17-hydroxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-fluoro-2-pyridinyl)propanamide
PubChem CID: 171390018
2D Structure
Properties
C26H29F2N3O2
Molecular Formula
453.50
Molecular Weight
g/mol
453.2228
Exact Mass
Da
4.7
XLogP
Drug-like (Lipinski: < 5)
74.6
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
764
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(17)
Linustedastat2254299-48-2PP3PLL7GZYRefChem:1088491Linustedastatumlinustedastat [INN]Linustedastat (USAN/INN)LINUSTEDASTAT [USAN]orb2663968DTXSID101376538EX-A13056OG-6219HY-159525D13078(15beta,17E)-4-Fluoro-N-(5-fluoro-2-pyridinyl)-17-(hydroxyimino)estra-1,3,5(10)-triene-15-propanamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Linustedastat
Loading drug network...